Daniel Lorber Rolnik MSc, MD, PhD, MPH

Daniel Lorber Rolnik is an Adjunct Associate Professor at Monash University. Daniel is an early career researcher and clinical epidemiologist who studied Medicine and specialized in Obstetrics and Gynaecology in Brazil (University of Sao Paulo), subspecialised in Fetal Medicine (Fetal Medicine Foundation / King's College Hospital, London, UK) and in Maternal-Fetal Medicine - High-risk pregnancy (Monash University - Australia). He has recently completed a Master in Public Health (MPH) in Epidemiology at Harvard University (USA).

His main research interest is in Obstetrics and Gynaecology, Prevention of pregnancy complications, Prenatal diagnosis, and Early pregnancy screening. In the last 5 years, Daniel has authored more than 90 peer-reviewed publications (H-index 24 (Google Scholar) and 24 (Scopus)) and has published in leading journals including NEJM, Lancet, JAMA, BMJ Open, American Journal of Obstetrics and Gynecology, Obstetrics and Gynecology, Human Reproduction, and Ultrasound in Obstetrics and Gynecology. Daniel recently led and first-authored a European multicentre landmark randomized trial on the prediction and prevention of pre-eclampsia involving nearly 27,000 screened women in 13 hospitals and six European countries. This study, published in NEJM, has changed clinical practice and had nearly 1400 citations in five years.